Legend Biotech Corporation Sponsored ADR (LEGN) reported $160.21 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 66.9%. EPS of -$0.34 for the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback